You just read:

Morphotek Announces Collaboration Agreement With The Johns Hopkins University To Research And Develop Novel Monoclonal Antibody-Based Therapies Targeting Missplicing-Associated Surface Antigens

News provided by

Morphotek, Inc.

Sep 06, 2017, 10:00 ET